[Management of patients with myocardial infarction: The delays]

Area of Science:

• Cardiology
• Emergency Medicine
• Interventional Cardiology

Context:

• Myocardial infarction (MI) management hinges on timely reperfusion to limit myocardial damage.
• The therapeutic window for reperfusion therapy is well-defined within the first 12 hours, with debated benefits up to 24 hours.
• Delays in reperfusion, particularly for primary angioplasty, often exceed recommended times due to diagnostic and logistical challenges.

Purpose:

• To underscore the critical importance of early reperfusion in acute myocardial infarction.
• To highlight the factors contributing to management delays in reperfusion therapy.
• To advocate for optimized patient pathways and prehospital interventions.

Summary:

• Early reperfusion of the culprit artery in myocardial infarction patients demonstrably reduces infarct size and mortality.
• The choice between primary angioplasty and fibrinolysis is contingent upon the 'first medical contact-to-balloon inflation' time.
• Inefficiencies in diagnosis (atypical symptoms, ECG interpretation) and management circuits contribute to prolonged treatment delays.

Impact:

• Implementing a streamlined management protocol, including direct emergency call, early prehospital care, and direct cath lab transfer or prehospital fibrinolysis, can significantly improve patient outcomes.
• Reducing delays in reperfusion therapy is crucial for maximizing the benefits of treatments like primary angioplasty.
• This approach aims to minimize mortality and infarct size in patients experiencing acute myocardial infarction.